| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/07/2005 | US20050147615 Compositions and methods for the therapy and diagnosis of colon cancer |
| 07/07/2005 | US20050147611 Combination therapy for conditions leading to bone loss |
| 07/07/2005 | US20050147609 and arthritis comprising administering of interleukin-17 and/or leukocyte inhibitory factor (LIF) antagonists, antibodies |
| 07/07/2005 | US20050147604 Means and methods for diagnosing and treating affective disorders |
| 07/07/2005 | US20050147602 Arterial remodeling, restenosis, fibrosis, formation of bone and cartilage; isolated nucleic acids and polypeptides; vectors, recombinant cells, antibodies. transgenic mammals |
| 07/07/2005 | US20050147601 Angiogenesis inhibitor; wound healing agents; prevent cell adhesion in mallals |
| 07/07/2005 | US20050147587 Protein fusion comprising colony stimulating factor activity for use as tool in rapid stimulation and production of white blood cells and neutrophils |
| 07/07/2005 | US20050147561 Method for identifying pesticidal active compounds |
| 07/07/2005 | US20050147556 analyzing for changes in levels of cancer specific genes (CSG) in cells, tissues or bodily fluids compared with levels of CSG in preferably the same cells, tissues, or bodily fluid type of a normal human control: administering antibodies conjugated to cytotoxic agents, which specifically bind CSG |
| 07/07/2005 | CA2551546A1 Preventive/remedy for cancer |
| 07/07/2005 | CA2551543A1 Method of suppressing cancer |
| 07/07/2005 | CA2551190A1 Polypeptides for modulating binding of trp channel proteins and trp-associated proteins. |
| 07/07/2005 | CA2551009A1 A respiratory syncytial virus with a genomic deficiency complemented in trans |
| 07/07/2005 | CA2550592A1 Identification of antigenically important neisseria antigens by screening insertional mutant libraries with antiserum |
| 07/07/2005 | CA2550482A1 Vaccine comprising an angiomotin or a polynucleotide encoding an angiomotin and its uses for the treatment of angiogenic-related disorders |
| 07/07/2005 | CA2550217A1 Glp-1 (9-36) methods and compositions |
| 07/07/2005 | CA2549956A1 Nogo-a neutralising immunoglobulins for treatment of neurological diseases |
| 07/07/2005 | CA2549796A1 Secreted neural apoptosis inhibiting proteins |
| 07/07/2005 | CA2549306A1 Methods of modulating cytokine activity; related reagents |
| 07/07/2005 | CA2549249A1 Muteins of fibroblast growth factor 21 |
| 07/07/2005 | CA2548740A1 Treatment of viral infections |
| 07/07/2005 | CA2548452A1 Medicament comprising inhibitors of long pentraxin ptx3 |
| 07/07/2005 | CA2523998A1 Novel antimicrobial peptides |
| 07/07/2005 | CA2522421A1 Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like protein |
| 07/06/2005 | EP1550722A1 Serotype of adenovirus and uses thereof |
| 07/06/2005 | EP1550720A1 Mutated androgen receptor, cancer cells expressing the same, method of constructing the same and use thereof |
| 07/06/2005 | EP1550673A1 Polyclonal antibodies, preparation method thereof and use of same |
| 07/06/2005 | EP1550672A1 Chimeric antagonist anth1 |
| 07/06/2005 | EP1550671A1 Placenta derived apoptotic factor |
| 07/06/2005 | EP1550669A1 Refolded membrane protein in monodisperse form |
| 07/06/2005 | EP1550453A1 Cancer antigen peptide preparation |
| 07/06/2005 | EP1550449A1 Antitumor agents with the use of hsv |
| 07/06/2005 | EP1549951A2 Semaphorin-like proteins and methods of using same |
| 07/06/2005 | EP1549771A2 Method for diagnosing pancreatic cancer |
| 07/06/2005 | EP1549763A2 Prophylactic and therapeutic hiv aptamers |
| 07/06/2005 | EP1549757A1 Method of purifying lantibiotics |
| 07/06/2005 | EP1549756A2 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 07/06/2005 | EP1549750A1 Modular antigen transporter molecules (mat molecules) for modulating immune reactions, associated constructs, methods and uses thereof |
| 07/06/2005 | EP1549748A1 Single chain recombinant t cell receptors |
| 07/06/2005 | EP1549747A2 Metalloprotease activation of myostatin, and methods of modulating myostatin activity |
| 07/06/2005 | EP1549746A1 Tryptophan as a functional replacement for adp-ribose-arginine in recombinant proteins |
| 07/06/2005 | EP1549738A2 Keratinocytes expressing exogenous angiogenic growth factors |
| 07/06/2005 | EP1549735A2 Circular dna molecule having a conditional origin of replication, process for their preparation and their use in gene therapy |
| 07/06/2005 | EP1549679A1 Fusion protein comprising angiopoietin receptor-binding and a multimerization domain |
| 07/06/2005 | EP1549676A1 Genes and polypeptides relating to human myeloid leukemia |
| 07/06/2005 | EP1549675A2 Glycosylated human interferon alpha isoform |
| 07/06/2005 | EP1549674A1 Crystal structure of erbb2 and uses thereof |
| 07/06/2005 | EP1549673A2 Novel mhc ii associated peptides |
| 07/06/2005 | EP1549672A2 Ablated slam-dependent entry |
| 07/06/2005 | EP1549671A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 07/06/2005 | EP1549665A2 Refolding of ionic channel proteins |
| 07/06/2005 | EP1549664A2 Murine ortholog of the human disrupted-in-schizophrenia 1 gene |
| 07/06/2005 | EP1549341A2 Novel tissue factor targeted antibodies as anticoagulants |
| 07/06/2005 | EP1549339A2 Targeting of herpes simplex virus to specific receptors |
| 07/06/2005 | EP1549338A1 Polypeptide-vaccines for broad protection against hypervirulent meningococcal lineages |
| 07/06/2005 | EP1549336A2 Prevention and/or treatment of inflammatory bowel disease using pyy or agonists thereof |
| 07/06/2005 | EP1549335A1 A method of modulating cellular activity and molecules for use therein |
| 07/06/2005 | EP1549333A1 Compstatin analogs with improved activity |
| 07/06/2005 | EP1549332A2 Modified asialo-interferons and uses thereof |
| 07/06/2005 | EP1468079A4 Dhfr-deficient cho cell line transfected with an anti-apoptotic gene, method for preparation thereof, and method for producing target protein using the same |
| 07/06/2005 | EP1450845A4 15603, a human ion channel family member |
| 07/06/2005 | EP1395108A4 Sugar and lipid metabolism regulators in plants |
| 07/06/2005 | EP1268531B1 Method for the production of bacterial toxins |
| 07/06/2005 | EP1222280B1 Apoptosis inducing proteinaceous substance |
| 07/06/2005 | EP1203021B1 New sequence variants of the human beta-1-adrenoreceptor genes and use thereof |
| 07/06/2005 | EP1145013B1 Removal of prions from blood, plasma and other liquids |
| 07/06/2005 | EP1140145B1 Novel exendin agonist formulations and methods of administration thereof |
| 07/06/2005 | EP1071442B1 Methods and compositions for peptide synthesis (t-20) |
| 07/06/2005 | EP1017837B1 Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site |
| 07/06/2005 | EP0870032B1 Polynucleotides and polypeptides in pathogenic mycobacteria and their use as diagnostics, vaccines and targets for chemotherapy |
| 07/06/2005 | EP0817846B1 Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies |
| 07/06/2005 | EP0730651B1 Surface loop structural analogues of fibroblast growth factors |
| 07/06/2005 | CN1636139A Detection of survivin in the biological fluids of cancer patients |
| 07/06/2005 | CN1636070A Nucleic acid encoding a G-protein-coupled receptor, and uses thereof |
| 07/06/2005 | CN1636067A TACIs and BR3 polypeptides and uses thereof |
| 07/06/2005 | CN1636064A Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 07/06/2005 | CN1636063A Genetic vaccine against human immunodeficiency virus |
| 07/06/2005 | CN1636060A Methods of delivery of exogenous proteins to the cytosol and uses thereof |
| 07/06/2005 | CN1636050A Core-glycosylated HCV envelope proteins |
| 07/06/2005 | CN1636017A Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer |
| 07/06/2005 | CN1636016A Methods to inhibit viral replication |
| 07/06/2005 | CN1636015A HCV e1e2 vaccine compositions |
| 07/06/2005 | CN1636014A Therapeutic use of a recombinant erythropoietin having high activity and reduced side effects |
| 07/06/2005 | CN1636013A DNA vaccines encoding HIV accessory proteins |
| 07/06/2005 | CN1636012A Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |
| 07/06/2005 | CN1635988A Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 07/06/2005 | CN1635905A Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS |
| 07/06/2005 | CN1635902A Remedy for infections |
| 07/06/2005 | CN1635901A Remodeling and glycoconjugation of peptides |
| 07/06/2005 | CN1635898A Super-active porcine growth hormone releasing hormone analog |
| 07/06/2005 | CN1635896A Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin useful for the treatment of cancer and infectious disease |
| 07/06/2005 | CN1635876A 人免疫缺陷病毒疫苗 Human immunodeficiency virus vaccine |
| 07/06/2005 | CN1635849A Bone anti-resorptive compounds |
| 07/06/2005 | CN1635832A Method for administering GLP-1 molecules |
| 07/06/2005 | CN1635117A Novel process for preparing recombinant Exendin-4 polypeptide |
| 07/06/2005 | CN1635111A Process for obtaining solid tumor related free protein in blood |
| 07/06/2005 | CN1634988A Atriopeptin production method |
| 07/06/2005 | CN1634987A Spleen polypeptide extract, its preparing process and use |
| 07/06/2005 | CN1634986A A novel Kunin type polypeptide and method for making same |
| 07/06/2005 | CN1634985A Pig Ghrelin derivative, its encoding gene and application |